Effective-compounds of Jinshui Huanxian formula ameliorates fibroblast activation in pulmonary fibrosis by inhibiting the activation of mTOR signaling.

BACKGROUND: Jinshui Huanxian formula (JHF) ameliorates idiopathic pulmonary fibrosis patients. Active compounds, including icariin, isoliquiritigenin, nobiletin, peimine, and paeoniflorin, deriving from JHF were combined as effective-component compatibility ECC of JHF II (ECC-JHF II), which is an effective therapeutic strategy for pulmonary fibrosis (PF) induced by bleomycin (BLM) in rats. PURPOSE: This study aimed to explore the underlying mechanism of ECC-JHF II on pulmonary fibrosis. METHODS: A model of PF in rats was established through intratracheal instillation of BLM. Pulmonary function, pathological changes, and collagen deposition were examined. The gene and protein expressions in fibroblast activation were detected by quantitative real-time PCR and western blotting respectively. RESULTS: ECC-JHF II significantly improved BLM-induced PF in rats, manifested as decreased collagen deposition, reduced pathological damage and improved pulmonary function. Furthermore, ECC-JHF II inhibited fibroblast activation by reducing the expression of α-smooth muscle actin (α-SMA) and fibronectin. We analyzed the targets of ECC-JHF II and differentially expressed genes (DEGs) of fibroblast activation induced by transforming growth factor-ß1 (TGF-ß1) and found that ECC-JHF II might regulate fibroblast activation by EGFR, PI3K-Akt or mTOR signaling pathway. In vitro experiments, we also found that ECC-JHF II suppressed the mTOR pathway, such as downregulating the phosphorylation levels of p70S6K in fibroblast activation induced by TGF-ß1. After activating mTOR signaling, the inhibition of ECC-JHF II on fibroblast activation was blocked. These results suggested that ECC-JHF II potently ameliorated pulmonary fibrosis in rats and effectively suppressed fibroblast activation by interfering with mTOR signaling. CONCLUSION: We combined transcriptomics with the network analysis to predict the mechanism underlying ECC-JHF II suppression of fibroblast activation. In summary, ECC-JHF II improved BLM-induced pulmonary fibrosis, which might be associated with the suppression of fibroblast activation by inhibiting the mTOR signaling.

Yangqing Chenfei formula attenuates silica-induced pulmonary fibrosis by suppressing activation of fibroblast via regulating PI3K/AKT, JAK/STAT, and Wnt signaling pathway.

BACKGROUND: Yangqing Chenfei formula (YCF) has been demonstrated its clinical efficiency on silicosis patients. However, the effect of YCF against silicotic fibrosis and its mechanism remain unclear. PURPOSE: This study is aimed to investigate active compounds and molecular mechanism of YCF in treating silicosis. METHOD: YCF was orally administrated to silicosis rats induced by crystalline silica. The effective fraction of YCF and the compounds was isolated and identified by using macroporous resin and HPLC-MS, respectively. The targets and potential molecular mechanism of YCF against silicotic fibrosis were investigated through pharmacological network and RNA-sequencing analysis and in vitro-experimental validation. RESULTS: YCF could remarkably improve the lung function and pathological changes of silicotic rats, reduce the aggregation of fibrocytes and deposition of ECM, such as collagen I, III, FN, and α-SMA, and suppress the TGF-ß/Smad3 signaling. Furthermore, YCF6, the effective fraction derived from YCF, could significantly inhibit fibroblast activation induced by TGF-ß. Then, 135 compounds were identified from YCF6 by using HPLC-MS, and Network pharmacology analysis predicted total 941 targets for these compounds. Moreover, 409 differentially expressed genes of fibroblast activation induced by TGF-ß were identified. Then, integrated analysis of the 941 targets with 409 differentially expressed genes showed that YCF6 contains multiple compounds, such as tangeretin, L-Malic acid, 2-Monolinolein etc., which inhibits fibroblast activation probably by targeting different proteins, such as PIK3CA, AKT1, JAK2, STAT3, GSK3ß, leading to regulate the signal network, such as PI3K/AKT signaling pathway, JAK/STAT signaling pathway, and Wnt signaling pathway. Finally, in vitro experiment indicated that tangeretin, the active compound contained in YCF6, could significantly inhibit TGF-ß induced fibroblast activation. Moreover, YCF6 and tangeretin could markedly inhibit the activation of PI3K/AKT, JAK/STAT, and Wnt pathway. CONCLUSION: YCF contained multiple compounds and targeted various proteins that regulated the fibroblast activation, which might be the molecular mechanisms of it in treating silicosis.

[Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].

OBJECTIVE: To investigate the effect of digoxin on bleomycin-induced pulmonary fibrosis in mice, and investigate its possible mechanism through in vitro and in vivo experiments. METHODS: (1) In vivo experiment: 60 C57/BL6J mice were randomly divided into control group, pulmonary fibrosis model group (model group), pirfenidone (300 mg/kg) group, digoxin 1.0 mg/kg and 0.2 mg/kg groups, with 12 mice in each group. The pulmonary fibrosis model of mice was reproduced by single intratracheal infusion of bleomycin (5 mg/kg). The control group was given the same amount of sterile normal saline. From the next day after modeling, each group was received corresponding drugs by intragastric administration once a day for 28 days. Control group and model group were given the same amount of normal saline. The mice were sacrificed and the lung tissue was collected to detect the lung coefficient. After hematoxylin-eosin (HE) and Masson staining, the lung tissue morphology and collagen changes were observed under light microscope. Immunohistochemistry was used to detect the positive expressions of α-smooth muscle actin (α-SMA) and extracellular matrix (ECM) collagen (COL-I and COL-III) in lung tissue. The protein expressions of ECM fibronectin (FN), transforming growth factor-ß (TGF-ß) and phosphorylation of Smad3 (p-Smad3) in lung tissue were detected by Western blotting. (2) In vitro experiment: human embryonic lung fibroblast-1 (HFL-1) cells were cultured and divided into blank control group, fibroblast activation model group (model group), pirfenidone (2.5 mmol/L) group and digoxin 100 nmol/L and 50 nmol/L groups when cell density reached 70%-90%. After 3-hour treatment with corresponding drugs, except blank control group, the other groups were treated with TGF-ß for 48 hours to establish fibroblast activation model. The expressions of α-SMA, FN and p-Smad3 proteins and the phosphorylations of phosphatidylinositol-3-kinase (PI3K)/Akt pathway proteins PI3K and Akt (p-PI3K, p-Akt) were detected by Western blotting. RESULTS: (1) In vivo, compared with the control group, the alveolar structure of mice in the model group was significantly damaged, a large number of inflammatory cells infiltrated, collagen deposition in the lung interstitium was increased, the deposition of ECM in the lung tissue was also increased, and the expressions of α-SMA, FN, TGF-ß and p-Smad3 protein were increased, indicating that the model of bleomycin-induced pulmonary fibrosis in mice was successfully prepared. Compared with the model group, digoxin significantly inhibited airway inflammation and collagen fiber deposition, reduced ECM deposition, and decreased the protein expressions of α-SMA, FN, TGF-ß and p-Smad3, while the effect was better than that of the pirfenidone group, and the digoxin 1.0 mg/kg group had a better effect except FN [α-SMA (A value): 5.37±1.10 vs. 9.51±1.66, TGF-ß protein (TGF-ß/GAPDH): 0.09±0.04 vs. 0.33±0.23, p-Smad3 protein (p-Smad3/GAPDH): 0.05±0.01 vs. 0.20±0.07, all P < 0.01]. (2) In vitro, compared with the blank control group, the expressions of FN, α-SMA, p-Smad3 and PI3K/Akt signaling proteins in the model group were increased, indicating that the fibroblast activation model induced by TGF-ß was successfully reproduced. Compared with the model group, digoxin significantly inhibited fibroblast activation, and decreased the expressions of FN, α-SMA, p-Smad3, and PI3K/Akt pathway proteins, moreover, the effect was better than that of the pirfenidone group, and decreased FN, SMA and p-Akt protein expressions were more obvious in digoxin 100 nmol/L group [FN protein (FN/GAPDH): 0.21±0.15 vs. 0.88±0.22, α-SMA protein (α-SMA/GAPDH): 0.20±0.01 vs. 0.50±0.08, p-Akt protein (p-Akt/GAPDH): 0.30±0.01 vs. 0.65±0.10, all P < 0.01]. CONCLUSIONS: Digoxin could suppress the pulmonary fibrosis in mice induced by bleomycin, which might be associated with the regulation of fibroblast activation via suppressing PI3K/Akt signaling pathway in a dose-dependent manner.

Synthesis and reactivity of a µ-1,2-dinitrogen dinickel(II) complex with a C-H activated silaamidinate pincer ligand.

Reaction of the silaamidinate nickel bromide LSi(NAr)2NiBr2Li(thf)(OEt2) (L = PhC(NtBu)2, Ar = 2,6-iPr2C6H3, 1) with NaHBEt3 led to intramolecular C-H activation with the formation of the µ-1,2-dinitrogen dinickel pincer complex [LSi(NAr)(NAr)Ni]2(µ-1,2-N2) (Ar = 2-C(CH3)2-6-iPrC6H3, 2). Single-crystal X-ray diffraction analysis of 2 disclosed a square planar Ni(II) atom bridged by N2. Reaction of 2 with carbon monoxide and 2,6-dimethylphenyl isocyanide yielded square planar carbonyl and isocyanide complexes 3 and 4 with release of N2. These results provide new approaches for the coordination of N2 with nickel(II) species.

Broadband dual-channel channelizer based on a microwave photonic power tunable image rejection down-conversion.

Radiofrequency (RF) channelization has potential high frequency and wideband advantages in frequency-domain channel segmentation and down-conversion reception. In this paper, we propose a compact dual-channel channelizer that can process high-frequency wideband signals. It uses double-polarization double-sideband electro-optic modulation and Hartley structure photoelectric conversion to realize down-conversion channelization of the high-frequency wideband signal. The power matching between two polarization signals can be realized by controlling the modulator bias, so the crosstalk between the two output signals can be suppressed. The proposed channelizer has a compact structure since the electro-optic modulation is based on one single laser and one single integrated modulator. No filters are used in the structure, contributing to a very wide RF operation bandwidth and low constraints of laser wavelength. In the experiment, the single frequency signal pairs from 9 GHz to 15 GHz can achieve an inter-channel image rejection ratio of 53 dB. Furthermore, the channelizer slices multi-octave bandwidth quadrature phase shift keying (QPSK) signals up to 16 GHz with the wideband isolation higher than 10 dB and outputs them to two channels in parallel. The error vector magnitudes (EVM) of 9-17 GHz and 18-26 GHz band QPSK signals are guaranteed to be under 23.58% after channelized separation. To the best of our knowledge, the proposed channelizer provides high inter-channel interference suppression at dual-band adjacent signals with 8 GHz bandwidth for the first time. Therefore, the proposed channelizer has great application value for the reception and processing of millimeter signals in the future.

Peimine ameliorates pulmonary fibrosis via the inhibition of M2-type macrophage polarization through the suppression of P38/Akt/STAT6 signals.

Peimine, a bioactive substance isolated from Chinese medicine Fritillaria, can potentially suppress pulmonary fibrosis (PF); however, its therapeutic mechanism remains unclear. Recent evidence suggests the participation of M2-type macrophages in the pathogenesis of PF. The present study aimed to investigate the effect of peimine on a bleomycin (BLM)-induced PF rat model and the underlying mechanism of this effect. After BLM administration, peimine was administered to rats from day 29 to day 42, with pirfenidone (PFD) as a positive control. H&E and Masson's trichrome stain were used to analyze histological changes. Q-PCR and western blotting were used to measure mRNA levels and protein levels, respectively. High-throughput RNA sequencing (RNA-seq) technology detected the differentially expressed genes (DEGs) regulated by peimine. Our results revealed that peimine treatment significantly ameliorated BLM-induced PF by suppressing histological changes and collagen deposition. In addition, peimine decreased the number of M2 macrophages and the expression of profibrotic factors. RNA-seq results showed that DEGs regulated by peimine in IL-4-induced macrophages were mainly associated with immune system processes, the PI3K/Akt pathway, and the MAPKs pathway. Then, immunofluorescence assay and western blot results demonstrated that peimine treatment suppressed the expression of p-p38 MAPK and p-Akt (s473) and also inhibited the nuclear translocation of p-STAT6. In conclusion, the present study demonstrated that peimine has a protective effect on PF through the suppression of M2 polarization of macrophages by inhibiting the STAT6, p38 MAPK, and Akt signals.

Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology.

BACKGROUND: Jinshui Huanxian formula (JHF), a traditional Chinese medicine (TCM), has been demonstrated to attenuate idiopathic pulmonary fibrosis (IPF). The active compounds and underlying mechanisms of JHF, however, are unclear. PURPOSE: The purpose of This study was to aimed to identify the active compounds and pharmacological mechanism of JHF by integrating serum pharmacochemistry with a network pharmacology strategy. METHODS: JHF was orally administered to a rat model with bleomycin (BLM)-induced pulmonary fibrosis (PF). The pharmacodynamic effects and compounds present in the serum were identified. The targets and biological mechanisms of these compounds were revealed using network analysis and validated using in vitro experiments. RESULTS: JHF could significantly ameliorate BLM-induced PF by preventing extracellular matrix collagen deposition. Twenty-seven compounds that were found to be enriched in the serum samples collected 1 h after oral administration with JHF were identified as the candidate active compounds, and their 423 potential targets were identified as JHF targets. primarily related to the advanced glycation and products-receptor for advanced glycation end products (AGE-RAGE) signaling pathway, phosphatidylinositol 3 kinase (PI3K)-protein kinase B (PKB or AKT) signaling pathway, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance, etc. The 423 targets, 1145 IPF-related genes and their overlapped genes were applied to analyze, respectively. The results showed that these genes were primarily related to the advanced glycation end-products-receptor for advanced glycation end-products (AGE-RAGE) signaling pathway, lipid and atherosclerosis pathology, phosphatidylinositol 3 kinase (PI3K)-protein kinase B (PKB or AKT) signaling pathway, and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance. Furthermore, the affinity between serum JHF compounds and the main proteins in the above important pathways was investigated through molecular docking. As a result, Molecular docking analysis showed that, tangeretin, isosinensetin, and peimine were found to could bind to EGFR and AKT, and their inhibitory effect on EGFR and AKT were validated in fibroblast cell induced by transforming growth factor (TGF)TGF-ß. The results indicated that suppression of fibroblast activation by inhibiting the EGFR/PI3K/AKT signaling pathway might be an important mechanism of JHF may to treat PF. CONCLUSION: JHF may suppress fibroblast activation by inhibiting the EGFR/PI3K/AKT signaling pathway to ameliorate PF. Tangeretin, isosinensetin, and peimine may be the active compounds in JHF involved in the treatment of that have therapeutic effects on IPF.

Effective-compound combination inhibits the M2-like polarization of macrophages and attenuates the development of pulmonary fibrosis by increasing autophagy through mTOR signaling.

BACKGROUND AND PURPOSE: The M2 polarization of macrophages substantially contributes to the progression of pulmonary fibrosis (PF). Effective-compound combination (ECC), which is composed of isoliquiritigenin, icariin, nobiletin, peimine, and paeoniflorin, ameliorated bleomycin-induced PF in rats. Hence, we investigated the anti-PF mechanism of ECC with a focus on the suppression of M2 polarization in macrophages in vivo and in vitro. METHODS: The PF rat model was generated via the intratracheal instillation of bleomycin. Histological changes, M2 macrophages, and profibrotic mediators were detected. The M2 polarization model was generated by incubating macrophages with IL-4. Quantitative PCR and Western blotting were used to measure mRNA and protein levels, respectively. RESULTS: ECC attenuated bleomycin-induced PF in rats, which might be associated with reduced macrophage infiltration, M2 polarization, and profibrotic mediator expression. Furthermore, ECC significantly suppressed M2 polarization in IL-4-treated macrophages, which was accompanied by the upregulation of autophagy. An autophagy inhibitor abrogated the inhibitory effect of ECC on M2 polarization. In addition, ECC decreased the levels of p-p70S6K/p-4EBP and p-AKT473/p-GSK3ß, which are critical regulators of autophagy. CONCLUSION: ECC can ameliorate PF, which might be associated with the inhibition of M2 polarization through the promotion of autophagy via mTOR signaling suppression.

Generation of rotational orbital angular momentum beams in the radio frequency based on an optical-controlled circular antenna array.

The orbital angular momentum (OAM) has been widely used in the wireless short-range communication system, but for long-distance communication, the huge difficulty of beam receiving is a great challenge. In this paper, to overcome this challenge, a generation system of radio-frequency rotational orbital angular momentum (RF-ROAM) beams based on an optical-controlled circular antenna array (CAA) is proposed. The ROAM beam is an OAM beam rotating at a certain speed around the beam axis. According to the rotational Doppler effect, the rotation of the OAM beam will induce a frequency shift proportional to the OAM mode and the rotation speed. Thereby, by rotating an OAM beam at a fixed speed scheduled in advance in the transmitting end, the beam can be mode-distinguished by just detecting the frequency shift without receiving the whole wavefront vertical to the beam axis in the receiving end. This provides a partial reception scheme for the OAM-based wireless communication system. The generation system of RF-ROAM beams is proposed and constructed, and the proof-of-concept experiment is performed. In the system, the optical-controlled CAA is constructed to generate the general RF-OAM beam, the optical signal processor (OSP) is employed to control the phase shifts to further control the OAM mode, and the signal with time-varying phase is generated as the rotation factor to control the rotation speed. In the experiment, the RF-ROAM beams with different mode and mode combination are generated and successfully measured by detecting the frequency shift of the signal received in a fixed point.

Analog radio of fiber link of 2-Gbaud OOK/BPSK radio frequency-orbital angular momentum beam transmission over 19.4 km.

The 5G mobile communication system provides ultrareliable, low-latency communications at up to 10 Gbps. However, the scale and power consumption of 5G is tremendous owing to a large number of antenna drivers required by the massive multiple-input multiple-output technique. The 6G system will require an architectural paradigm shift to resolve this problem. In this study, we propose an analog RoF downlink scheme for 6G wireless communications. The upcoming oversized base station problem is solved using photonics techniques. The antennas are driven together within the optical domain at a centralized station. The proposed system uses orbital angular momentum (OAM) beams as the generated space-division-multiplexing beams. An RF-OAM beam has a weak coupling effect between different modes, which will dramatically decrease the complexity of the signal processing. In our proof-of-concept experiment, the generated RF-OAM beam was shown to carry a 2-Gbaud OOK/BPSK signal in the Ku-band. Signals were transmitted over a 19.4-km RoF link without dispersion-induced power fading. In addition, by switching the OAM beams, a two-dimensional direction scanning was achieved.

Chromatic dispersion immune microwave photonic phase shifter based on double-sideband modulation.

A chromatic dispersion (CD) immune microwave photonic phase shifter (MPPS) based on double-sideband (DSB) modulation is proposed and demonstrated. An optical spectrum processor introduces the phase shift to the MPPS. The DSB signals along two orthogonal polarizations are demodulated to two RF signals with both quadrature amplitude and phase items, transferring the CD-induced power fading to the phase item of the synthetic RF signals. Experimental results show that the RF signals over 14-25 GHz obtain random phase shift in 360° range without a power fading point (PFP) after passing through a dispersion compensation fiber with CD of -331 ps/nm. The phase variation and power variation of the phase-shifted signal are <±5.7° and <±0.9 dB, respectively, at the original PFP at 16 GHz.

Photonic generation of background-free binary and quaternary phase-coded microwave pulses based on vector sum.

A photonic microwave phase-coded pulse generator is proposed and experimentally demonstrated based on the principle of vector sum. The key component of the proposed pulse generator is an integrated polarization-division multiplexing Mach-Zehnder modulator (PDM-MZM) and a 90° hybrid coupler. By properly setting the data sequences applied to the specially biased PDM-MZM, binary and quaternary phase-coded microwave pulses (PCMPs) that are free from the background signals can be generated. Since no filters and polarization adjustment are involved, the proposed pulse generator is characterized by a simple structure, low-loss, flexible frequency tunability and high long-term stability. The experimental results show that background-free 4 Gb/s Barker and Frank PCMPs at 18 GHz and 2 Gb/s Barker and Frank PCMPs at 24 GHz are successfully generated. The calculated pulse compression ratio and peak-to-side lobe ratio are in good agreement with the theoretical values.

Equivalent photonic switch for microwave frequency shift keying signal generation.

A photonic microwave frequency shift keying (FSK) signal generator is proposed and experimentally demonstrated based on an equivalent photonic switch (EPS). The EPS is constructed using a polarization-multiplexing dual-drive Mach-Zehnder modulator (PM-DMZM). By properly controlling the data sequences and RF signals applied to the PM-DMZM, microwave FSK signals with flexible frequency intervals can be obtained. The proposed FSK signal generator features the advantages of a simple structure, low loss, good stability, and great frequency tunability. In addition, the proposed setup can also be easily reconfigured to generate microwave amplitude shift keying and phase shift keying signals. The experimental results show that 2 Gb/s at 5/14 GHz and 1 Gb/s at 6/20 GHz microwave FSK signals are successfully generated, after transmission over 5 km single-mode fiber. The required received optical power at 7% forward error correction threshold is only -14.48 dBm.

Broadband chromatic-dispersion-induced power-fading compensation for radio-over-fiber links based on Hilbert transform.

A Hilbert-transform-based broadband chromatic dispersion (CD) compensation scheme for radio-over-fiber links is proposed and experimentally demonstrated. By constructing a Hilbert transform path, CD-induced phase shifts, which initially lead to periodic power fading of the output RF signals, are transferred to the phases of the RF signals. As a result, the powers of the output RF signals are free from the effect of CD in a broadband frequency range. Experimental results show that a flat normalized amplitude-frequency response is actualized within 2-24 GHz, with only 3.02 dB/4.27 dB power fluctuation after transmission over an equivalent of a 38.6 km/43.6 km single-mode fiber. Besides, compared with a conventional dispersive path, the proposed CD compensation scheme significantly improves the third-order spurious-free dynamic range by 23.60 dB.

Effect of Comprehensive Therapy based on Chinese Medicine Patterns on Self-Efficacy and Effectiveness Satisfaction in Chronic Obstructive Pulmonary Disease Patients.

OBJECTIVE: To evaluate the effect of comprehensive therapy based on Chinese medicine (CM) patterns on self-efficacy and satisfaction with its effectiveness in patients with chronic obstructive pulmonary disease (COPD). METHODS: A total of 216 patients were randomly divided into the trial group (n =108) and the control group (n=108) based on the stratified and block randomization design. Patients in the trial group were treated with conventional Western medicine combined with Bufei Jianpi Granules (), Bufei Yishen Granules (), and Yiqi Zishen Granules () according to the CM patterns respectively, and patients in the control group were treated with conventional Western medicine. The COPD Self-Efficacy Scale (CSES) and the Effectiveness Satisfaction Questionnaire for COPD (ESQ-COPD) were employed in a 6-month treatment and in further 6 month follow-up visit. RESULTS: Among the 216 patients, 191 patients (97 in the trial group and 94 in the control group) fully completed the study. After 12-month treatment and follow-up, the mean scores of the trial group all continued to increase over time, which were significantly higher than those of the control group (P <0.05), and the improvement in the following trial group domain: negative affect domain (12.13%), intense emotional arousal domain (12.21%), physical exertion domain (11.72%), weather/environmental domain (13.77%), behavioral risk domain (7.67%) and total score (10.65%). The trial group also exhibited significantly higher mean scores in the ESQ-COPD (P <0.05) and the improvement in the following domain: capacity for life and work domain (30.59%), clinical symptoms domain (53.52%), effect of therapy domain (35.95%), convenience of therapy domain (35.54%), and whole effect domain (52.47%). CONCLUSIONS: Bufei Jianpi Granules, Bufei Yishen Granules and Yiqi Zishen Granules can improve the self-efficacy and satisfaction of COPD patients.

A pharmacological approach to study the active compounds in Jinshui Huanxian formula in treatment of pulmonary fibrosis.

OBJECTIVE: To study the active compounds in Jinshui Huanxian formula in the treatment of pulmonary fibrosis with a pharmacological approach. METHODS: A systems pharmacology model, incorporating active compounds and targets prediction, and herbal-compound-target-disease network analysis, was established to predict the active substances and therapeutic mechanisms of Jinshui Huanxian formula. All compounds from the herbs of Jinshui Huanxian formula were obtained from drug database and the literature. Then, we analyzed the potential of herbs by predicting oral bioavailability and drug-likeness index. The com- pounds with oral bioavailability ≥ 30% and drug-likeness index ≥ 0.18 were obtained as candidate compounds for further analysis. We then used the systematic drug targeting tool to screen the targets for candidate compounds. The potential targets were projected into Therapeutic Target Database to collect their corresponding diseases. The candidate compounds, potential targets and their related diseases were applied to construct the compound-target and target-disease network. RESULTS: Totally 136 compounds from Jinshui Huanxian formula and 265 potential targets were found. Compound-target network analysis suggested that different herbal drugs contained in the Jinshui Huanxian formula could regulate these similar targets to probably exert synergistic effect. Moreover, target proteins were mainly related to oxidoreductase activity, nicotinamide adenine dinucleotide phosphate binding, and G-protein coupled amine receptor activity, which might be associated with the therapeutic mechanisms of Jinshui Huanxian formula. In addition, Jinshui Huanxian formula was probably efficient for many different diseases, such as respiratory tract diseases, neoplasm, nervous system diseases, and cardiovascular diseases, according to target-disease network. CONCLUSION: This study may provide a method to explore the potential active compounds in Jinshui Huanxian formula used to treat pulmonary fibrosis.

An arene-tethered silylene ligand enabling reversible dinitrogen binding to iron and catalytic silylation.

An arene-tethered silylene ligand, L (L = PhC(tBuN)2SiCH2C(tBu)NAr, Ar = 2,6-iPr2C6H3), allowed the synthesis of three-coordinate Fe(ii) silylamido and piano-stool Fe(0) dinitrogen complexes LFe[N(SiMe3)2]2 (3) and LFe-N2 (4), which not only exhibit interesting bonding but also enabled the catalytic silylation of N2 to yield N(SiMe3)3 under 1 atm of N2 at room temperature with high TONs.

A Chinese Herbal Formula Ameliorates Pulmonary Fibrosis by Inhibiting Oxidative Stress via Upregulating Nrf2.

This study aimed to explore the protective effects of a Chinese herbal formula, Jinshui Huanxian formula (JHF), on experimental pulmonary fibrosis and its underlying mechanisms. After being treated with single dose of bleomycin (5 mg/kg) intratracheally, rats were orally administered with JHF and pirfenidone from day 1 to 42, then sacrificed at 7, 14, 28, or 42 days post-bleomycin instillation. JHF ameliorated bleomycin-induced pathological changes, collagen deposition in the rat lung and recovered pulmonary function at different days post-bleomycin instillation. In lungs of JHF-treated rats, the levels of total superoxide dismutase, catalase and glutathione were higher, and myeloperoxidase and methane dicarboxylic aldehyde were lower than those in vehicle-treated rats, respectively. Additionally, JHF inhibited the expression of NADPH oxidase 4 (NOX4) and increased the Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in lung tissues. In vitro, JHF and ruscogenin, a compound of Ophiopogonis Radix contained in JHF, significantly inhibited transforming growth factor ß1 (TGF-ß1)-induced differentiation of fibroblasts. Furthermore, JHF markedly decreased the level of reactive oxygen species in TGF-ß1-induced fibroblast. In line with this, upregulation of NAD(P)H: quinone oxidoreductase 1 and heme oxygenase 1, and downregulation of NOX4 were found in JHF-treated fibroblast induced by TGF-ß1. While on the other hand, Nrf2 siRNA could suppress the JHF-mediated inhibition effect on alpha-smooth muscle actin (α-SMA), and FN1 expression induced by TGF-ß1 in fibroblasts. These results indicated that JHF performed remarkably therapeutic and long-term effects on pulmonary fibrosis in rat and suppressed the differentiation of fibroblast into myofibroblast through reducing the oxidative response by upregulating Nrf2 signaling. It might provide a new potential natural drug for the treatment of pulmonary fibrosis.

Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations.

Chronic obstructive pulmonary disease (COPD) is a serious health problem. However, the molecular pathogenesis of COPD remains unknown. Here, we explored the molecular effects of cigarette smoke and bacterial infection in lung tissues of COPD rats. We also investigated therapeutic effects of aminophylline (APL) on the COPD rats and integrated transcriptome, proteome, and metabolome data for a global view of molecular mechanisms of COPD progression. Using molecular function and pathway analyses, the genes and proteins regulated in COPD and APL-treated rats were mainly attributed to oxidoreductase, antioxidant activity, energy and fatty acid metabolism. Furthermore, we identified hub proteins such as Gapdh (glyceraldehyde-3-phosphate dehydrogenase), Pkm (pyruvate kinase isozymes M1/M2), and Sod1 (superoxide dismutase 1), included in energy metabolism and oxidative stress. Then, we identified the significantly regulated metabolic pathways in lung tissues of COPD- and APL-treated rats, such as arachidonic acid, linoleic acid, and α-linolenic acid metabolism, which belong to the lipid metabolism. In particular, we picked the arachidonic acid metabolism for a more detailed pathway analysis of transcripts, proteins, and metabolites. We could observe an increase in metabolites and genes involved in arachidonic acid metabolism in COPD rats and the decrease in these in APL-treated rats, suggesting that inflammatory responses were up-regulated in COPD rats and down-regulated in APL-treated rats. In conclusion, these system-wide results suggested that COPD progression and its treatment might be associated with oxidative stress, lipid and energy metabolism disturbance. Additionally, we demonstrated the power of integrated omics for the elucidation of genes, proteins, and metabolites' changes and disorders that were associated with COPD.

Cobalt-Catalyzed Regioselective Borylation of Arenes: N-Heterocyclic Silylene as an Electron Donor in the Metal-Mediated Activation of C-H Bonds.

C-H Borylation of arenes has been a subject of great interest recently because of its atom-economy and the wide applicability of borylated products in value-added synthesis. A new bis(silylene)cobalt(II) complex bearing a bis(N-heterocyclic silylene)-pyridine pincer ligand (SiNSi) has been synthesized and structurally characterized. It enabled the regioselective catalytic C-H borylation of pyridines, furans, and fluorinated arenes. Notably, it exhibited complementary regioselectivity for the borylation of fluorinated arenes compared to previously known catalytic systems, demonstrating that N-heterocyclic silylene donors have enormous potential in metal-catalyzed catalytic applications.